Report
Global Healthcare M&A: H1’20 Update
This H1 2020 update analyzes global healthcare M&A activity during a period of unprecedented disruption caused by the COVID-19 pandemic. Lockdowns, economic uncertainty, and operational challenges significantly affected global markets, with the World Bank forecasting a contraction in economic activity during 2020. As countries gradually reopened businesses and resumed economic activity, healthcare remained a key focus for investors due to its critical role in addressing the pandemic and supporting public health. However, concerns about recurring outbreaks and potential second waves of COVID-19 continued to create uncertainty around recovery prospects and dealmaking activity. Despite these challenges, the healthcare sector demonstrated resilience, supported by ongoing demand for pharmaceuti
